AST SpaceMobile vs. Firefly Aerospace: Which Outer Space Upstart Is a Better Buy in 2026?

The article compares AST SpaceMobile (ASTS) vs. Firefly Aerospace (FLY), highlighting that ASTS targets direct-to-device satellite connectivity with FY2025 revenue of ~$70.9M (vs. ~$4.4M prior year) but a net loss of ~-$342M and highly negative margins (-482.2%), alongside a high P/S of 149x. Firefly shows faster revenue growth in defense/lunar launch services (FY2025 revenue ~$159.9M, +163% YoY) with a net loss of ~-$298.3M and negative margins (-186.6%), but a much lower P/S of 12.9x and comparatively more conservative leverage (debt-to-equity ~0.3x). Overall, the piece frames both as high execution-risk, cash-burn phases with speculative upside, with Firefly positioned as the more conservatively valued option.

Analysis

This is less a debate about space TAM than about which model needs less capital to get to proof. FLY’s advantage is that its revenue path is budgeted and milestone-driven, so the equity story is more about execution than repeated financing; that usually supports a higher-quality multiple even if the headline growth rate is lower. ASTS is more convex, but the market should treat it as a sequence of funding bridges: each constellation milestone reduces uncertainty, yet each delay raises dilution risk and can reset the equity base.

Second-order effects matter more than the article implies. If ASTS ultimately works, the long-run losers are not just IRDM/GSAT; it also creates pricing pressure on carrier-owned satellite messaging and forces incumbents to defend retention with bundled services rather than pure network quality. On the flip side, FLY’s success is actually most supportive for the defense primes and subcontractor ecosystem (LMT/NOC), because it increases demand for integrated mission payloads, launch slots, and data processing without requiring mass-market consumer adoption.

The near-term risk window is days to weeks for ASTS financing headlines and launch/satellite anomalies, versus months for FLY contract cadence and U.S. budget digestion. The consensus may be underpricing how quickly ASTS can be diluted if markets turn risk-off, while also underestimating how much optionality a successful commercial rollout could add if the next 2-3 milestones hit cleanly. Base case: FLY is the better risk-adjusted way to own space, but ASTS has the sharper upside if execution and funding align.

Key Decisions for Investors

• Initiate a beta-adjusted long FLY / short ASTS pair for the next 3-6 months; thesis is lower dilution risk and better cash-flow visibility versus a higher-multiple, financing-dependent buildout.
• If ASTS rallies on partnership or launch headlines, use strength to add to the short only after confirming the move is not paired with non-dilutive funding or an accelerated deployment schedule.
• For investors wanting long-only exposure, prefer FLY common or 6-9 month call spreads over ASTS until the next two milestones and financing terms are known; avoid paying up for ASTS implied volatility.
• Set an alert on ASTS for any equity raise, convertible issuance, or schedule slip; that would be the clearest falsifier and likely the best entry to press the relative short.
• Watch IRDM and GSAT as longer-dated competitive hedges: if ASTS proves direct-to-device economics, these names face valuation compression, but that trade is premature until ASTS de-risks deployment.